Advanced Life Sciences Presents Clinical Data On Selected Cethromycin Trials At The Infectious Diseases Society Of America 44th Annual Meeting

... Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS) presented, for the first time, clinical results comparing the safety and efficacy of cethromycin at varying doses for the treatment of acute bacterial sinusitis (ABS) at the 44th Annual Meeting of the Infectious Diseases Society of America (IDSA). This year's meeting took place in Toronto, Ontario. [click link for full article] ...